The dual efficacy of the inhibitor (D)-LYIWIWRT suggests that Aβ and tau, share a common structural motif in AD and that there is a direct interaction between the Aβ core and the amyloid-prone regions of tau. This evidence concerns the gene MAPT and Alzheimer disease.